(Q39632700)

English

177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi

scientific article published on 12 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

based on heuristic

inferred from title

peritoneal carcinomatosis

1 reference

based on heuristic

inferred from title

Leticia Quintanilla-Martinez

4

object named as

Leticia Quintanilla-Martinez

0 references

Reingard Senekowitsch-Schmidtke

6

object named as

Reingard Senekowitsch-Schmidtke

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1

object named as

Christof Seidl

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Frank Bruchertseifer

5

object named as

Frank Bruchertseifer

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Christine Zöckler

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Roswitha Beck

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

12 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

312-322

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

https://scigraph.springernature.com/pub.10.1007/s00259-010-1639-2

0 references

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Optimal locoregional treatment in gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Pathogenesis and treatment of gastric carcinoma: "an up-date with brief review".

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Adjuvant therapy in gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Chemotherapy for metastatic gastric cancer: past, present, and future

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Mutations of the human E-cadherin (CDH1) gene.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Peptide-receptor radionuclide therapy for endocrine tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Radioimmunotherapy of prostate cancer using 90Y- and 177Lu-labeled J591 monoclonal antibodies: effect of multiple treatments on myelotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1639-2

21 January 2018

Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced myelotoxicity with sustained tumor concentration of radioimmunoconjugates in rats after extracorporeal depletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

213Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21072513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-010-1639-2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39632700&oldid=1848633627"